The Current Ratio as of November 2025 (TTM) for Living Cell Technologies Limited (LVCLY) is 17.89

According to Living Cell Technologies Limited’s latest financial reports and current stock price. The company's current Current Ratio is 17.89. This represents a change of 1.27% compared to the average of 17.67 of the last 4 quarters.

Living Cell Technologies Limited (LVCLY) Historical Current Ratio (quarterly & annually)

How has LVCLY Current Ratio performed in the past?

The mean historical Current Ratio of Living Cell Technologies Limited over the last ten years is 11.14. The current 17.89 Current Ratio has changed 15.95% with respect to the historical average. Over the past ten years (40 quarters), LVCLY's Current Ratio was at its highest in in the December 2023 quarter at 26.81. The Current Ratio was at its lowest in in the December 2004 quarter at 0.

Living Cell Technologies Limited (LVCLY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Living Cell Technologies Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Living Cell Technologies Limited (LVCLY) Average Current Ratio

How has LVCLY Current Ratio performed in the past?

The current Current Ratio of Living Cell Technologies Limited (LVCLY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Living Cell Technologies Limited (LVCLY) Current Ratio vs. Peers

How is LVCLY’s Current Ratio compared to its peers?

Living Cell Technologies Limited’s Current Ratio is greater than Avecho Biotechnology Limited (4.62), greater than Ceapro Inc. (8.54), greater than Eiger BioPharmaceuticals, Inc. (0.71), greater than Poxel S.A. (0.34), greater than Bionomics Limited (2.72), greater than Rapid Dose Therapeutics Corp. (0.09), greater than Antibe Therapeutics Inc. (15.03), greater than LexaGene Holdings Inc. (7.12), greater than Verici Dx plc (2.24), greater than Noxopharm Limited (1.18),

Build a custom stock screener for Living Cell Technologies Limited (LVCLY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Living Cell Technologies Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Living Cell Technologies Limited (LVCLY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Living Cell Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.